Edouard Mullarky

6.2k total citations · 3 hit papers
13 papers, 3.4k citations indexed

About

Edouard Mullarky is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Edouard Mullarky has authored 13 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Biochemistry. Recurrent topics in Edouard Mullarky's work include Cancer, Hypoxia, and Metabolism (10 papers), Amino Acid Enzymes and Metabolism (6 papers) and Epigenetics and DNA Methylation (6 papers). Edouard Mullarky is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Amino Acid Enzymes and Metabolism (6 papers) and Epigenetics and DNA Methylation (6 papers). Edouard Mullarky collaborates with scholars based in United States, Belgium and Sweden. Edouard Mullarky's co-authors include Lewis C. Cantley, John M. Asara, Costas A. Lyssiotis, Alec C. Kimmelman, Xiaoxu Wang, Cristina R. Ferrone, Sujun Hua, Ng Shyh‐Chang, Matteo Ligorio and Ya’an Kang and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Edouard Mullarky

13 papers receiving 3.4k citations

Hit Papers

Glutamine supports pancre... 2013 2026 2017 2021 2013 2015 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
    2013 1.5k citations Jaekyoung Son, Costas A. Lyssiotis et al. Nature profile →
  2. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
    2015 696 citations Jihye Yun, Edouard Mullarky et al. Science profile →
  3. NRF2 regulates serine biosynthesis in non–small cell lung cancer
    2015 560 citations Gina M. DeNicola, Pei-Hsuan Chen et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edouard Mullarky United States 12 2.3k 1.8k 659 409 345 13 3.4k
Volkan I. Sayin Sweden 17 2.1k 0.9× 862 0.5× 376 0.6× 146 0.4× 177 0.5× 41 3.0k
Lan‐Feng Dong Australia 37 2.5k 1.1× 1.2k 0.7× 479 0.7× 87 0.2× 248 0.7× 79 3.8k
Francesco Feo Italy 37 2.4k 1.1× 828 0.5× 640 1.0× 375 0.9× 98 0.3× 111 3.8k
Christiaan F. Labuschagne United Kingdom 15 2.2k 1.0× 1.4k 0.8× 632 1.0× 308 0.8× 66 0.2× 21 3.2k
Julián Carretero Spain 32 1.8k 0.8× 580 0.3× 638 1.0× 265 0.6× 86 0.2× 59 2.9k
Yumin Hu China 33 2.4k 1.0× 1.2k 0.7× 630 1.0× 141 0.3× 82 0.2× 76 3.8k
Frank Weinberg United States 19 2.1k 0.9× 1.2k 0.7× 540 0.8× 138 0.3× 81 0.2× 46 3.3k
Elena Piskounova United States 13 2.9k 1.2× 1.7k 1.0× 895 1.4× 67 0.2× 169 0.5× 22 4.1k
Elma Zaganjor United States 19 2.7k 1.2× 1.4k 0.8× 414 0.6× 109 0.3× 219 0.6× 26 3.9k
Saroj P. Mathupala United States 24 2.6k 1.1× 2.1k 1.2× 479 0.7× 99 0.2× 139 0.4× 32 3.6k

Countries citing papers authored by Edouard Mullarky

Since Specialization
Citations

This map shows the geographic impact of Edouard Mullarky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edouard Mullarky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edouard Mullarky more than expected).

Fields of papers citing papers by Edouard Mullarky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edouard Mullarky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edouard Mullarky. The network helps show where Edouard Mullarky may publish in the future.

Co-authorship network of co-authors of Edouard Mullarky

This figure shows the co-authorship network connecting the top 25 collaborators of Edouard Mullarky. A scholar is included among the top collaborators of Edouard Mullarky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edouard Mullarky. Edouard Mullarky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gomes, Ana P., Didem Ilter, Vivien Low, et al.. (2022). Altered propionate metabolism contributes to tumour progression and aggressiveness. Nature Metabolism. 4(4). 435–443. 54 indexed citations
2.
Jeong, Sangmoo, Angela Maria Savino, Rachel Chirayil, et al.. (2020). High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells. Cell Metabolism. 33(1). 145–159.e6. 51 indexed citations
3.
Mullarky, Edouard, Jiayi Xu, David J. Huggins, et al.. (2019). Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells. Bioorganic & Medicinal Chemistry Letters. 29(17). 2503–2510. 41 indexed citations
4.
Holt, Melissa C., Reza Beheshti Zavareh, Lin Lin, et al.. (2018). Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors. Biochemistry. 57(47). 6604–6614. 27 indexed citations
5.
Anglin, Justin L., Reza Beheshti Zavareh, Philipp N. Sander, et al.. (2018). Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorganic & Medicinal Chemistry Letters. 28(16). 2675–2678. 29 indexed citations
6.
Ravez, Séverine, Cyril Corbet, Quentin Spillier, et al.. (2017). α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH). Journal of Medicinal Chemistry. 60(4). 1591–1597. 55 indexed citations
7.
Mullarky, Edouard, Natasha C. Lucki, Reza Beheshti Zavareh, et al.. (2016). Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proceedings of the National Academy of Sciences. 113(7). 1778–1783. 251 indexed citations
8.
Mullarky, Edouard, Luke L. Lairson, Lewis C. Cantley, & Costas A. Lyssiotis. (2016). A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase. Molecular & Cellular Oncology. 3(4). e1164280–e1164280. 22 indexed citations
9.
Yun, Jihye, Edouard Mullarky, Kaitlyn Bosch, et al.. (2015). Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 350(6266). 1391–1396. 696 indexed citations breakdown →
10.
DeNicola, Gina M., Pei-Hsuan Chen, Edouard Mullarky, et al.. (2015). NRF2 regulates serine biosynthesis in non–small cell lung cancer. Nature Genetics. 47(12). 1475–1481. 560 indexed citations breakdown →
11.
Son, Jaekyoung, Costas A. Lyssiotis, Haoqiang Ying, et al.. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 496(7443). 101–105. 1491 indexed citations breakdown →
12.
Langenhan, Joseph M., et al.. (2013). Amphimedosides A–C: Synthesis, Chemoselective Glycosylation, And Biological Evaluation. The Journal of Organic Chemistry. 78(4). 1670–1676. 10 indexed citations
13.
Mullarky, Edouard, Katherine Mattaini, Matthew G. Vander Heiden, Lewis C. Cantley, & Jason W. Locasale. (2011). PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell & Melanoma Research. 24(6). 1112–1115. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Volkan I. Sayin Breakdown of academic impact, for papers by Lan‐Feng Dong Breakdown of academic impact, for papers by Francesco Feo Breakdown of academic impact, for papers by Christiaan F. Labuschagne Breakdown of academic impact, for papers by Julián Carretero Breakdown of academic impact, for papers by Yumin Hu Breakdown of academic impact, for papers by Frank Weinberg Breakdown of academic impact, for papers by Elena Piskounova Breakdown of academic impact, for papers by Elma Zaganjor Breakdown of academic impact, for papers by Saroj P. Mathupala
Rankless by CCL
2026